![Nicole Jones](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nicole Jones
Investor Relations Contact chez
ACHIEVE LIFE SCIENCES, INC.
Profil
Nicole Jones is currently VP-Strategic Communications & IR Contact at Achieve Life Sciences, Inc. since 2025.
Formerly, Ms. Jones worked as an Analyst at Flyover Capital Partners LLC.
Ms. Jones completed undergraduate and graduate degrees at the University of Kansas.
Postes actifs de Nicole Jones
| Sociétés | Poste | Début |
|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. | Investor Relations Contact | 01/08/2025 |
Anciens postes connus de Nicole Jones
| Sociétés | Poste | Fin |
|---|---|---|
Flyover Capital Partners LLC
 Flyover Capital Partners LLC Investment ManagersFinance Flyover Capital invests in companies located in the United States. The firm focuses on the technology sector. It provides financing for seed and early-stage capital requirements with an investment size of USD 0.5 - 2 million and transaction size of USD 1 - 5 million. | Analyste en capital-investissement | - |
Formation de Nicole Jones
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
22
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
University of Kansas
 University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Flyover Capital Partners LLC
Flyover Capital Partners LLC Investment ManagersFinance Flyover Capital invests in companies located in the United States. The firm focuses on the technology sector. It provides financing for seed and early-stage capital requirements with an investment size of USD 0.5 - 2 million and transaction size of USD 1 - 5 million. | Finance |
Achieve Life Sciences, Inc.
 Achieve Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cytisinicline for smoking cessation and nicotine addiction | Health Technology |
